Pharmaceuticals, Biotechnology and Life Sciences
DURHAM, N.C., May 16, 2022 (GLOBE NEWSWIRE) — NightHawk Biosciences (NYSE American: NHWK), a fully integrated biopharmaceutical company focused on…
Management to host webcast/conference call today at 2 p.m. PT / 5 p.m. ETSAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE)…
SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics,…
FORT WORTH, TX , May 16, 2022 (GLOBE NEWSWIRE) — Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”)…
Focus on Optimizing Inventory in Connecticut and Production Capacity in ArizonaImproving Positioning for Early-Stage Recreational Market OpportunitiesProvides Revised Guidance for…
LAS VEGAS, May 16, 2022 (GLOBE NEWSWIRE) — Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator of clinically proven plant-based…
– $130 Million in Non-Dilutive Capital Strengthened Financial Position – – Presentations at Upcoming ASGCT Annual Meeting Include First-Time Details…
WALTHAM, Mass. and SHANGHAI, China, May 15, 2022 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming…
Orphazyme A/S in restructuringCompany announcementNo. 24/2022Inside informationwww.orphazyme.comCompany Registration No. 32266355 KemPharm to acquire Orphazyme assets, including those relating to…
Sarclisa® (isatuximab) combination provides unprecedented median progression free survival in patients with relapsed multiple myeloma receiving a proteasome inhibitor therapy…